Mapping MAGE-A4 expression in solid cancers for targeted therapies.
Saved in:
| Title: | Mapping MAGE-A4 expression in solid cancers for targeted therapies. |
|---|---|
| Authors: | Habigt C; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Munich, Penzberg, Germany., Rottey S; Department of Medical Oncology, UZ Gent, Ghent, Belgium., Spanggaard I; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Lopez JS; Phase I Drug Development Unit, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Garralda E; Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain., Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain., Bechter O; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium., Desai J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Galot R; Université Catholique de Louvain and Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Gandhi L; Early Drug Development Center, Dana-Farber Cancer Institute, Boston, MA, United States., Heil F; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Munich, Penzberg, Germany., Rieder N; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Munich, Penzberg, Germany., Dimitrov I; CDx Pharma Services Assay Development, Roche Tissue Diagnostics, Tucson, AZ, United States., Quetglas IM; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Zurich, Zurich, Switzerland., Heichinger C; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Basel, Basel, Switzerland., Keshelava N; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Zurich, Zurich, Switzerland., Roller A; Roche Pharma Research and Early Development, Early Development Oncology, Roche Innovation Center Basel, Basel, Switzerland. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Mar 13; Vol. 15, pp. 1484182. Date of Electronic Publication: 2025 Mar 13 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1484182 |
